☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Weekly Snapshots (January 31 – February 04, 2022)
February 4, 2022
Timber Reports Completion of End-of-P-II Meeting with the US FDA for to Treat Congenital Ichthyosis
February 4, 2022
UroGen Initiates P-III (ENVISION) Study of UGN-102 for the Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Ca...
February 4, 2022
AstraZeneca Entered into an Exclusive License Agreement with Regio Biosciences to Initiate P-IIa Trial of REG-101 for Peripheral A...
February 4, 2022
Seagen Reports Results of Adcetris in P-III (ECHELON-1) Clinical Trial for the Treatment of Advanced Hodgkin Lymphoma
February 4, 2022
Amgen Signs an Exclusive Multi-Year Research Collaboration and License Agreement with Plexium to Advance Novel Targeted Protein De...
February 4, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions